AcelRx Pharmaceuticals (ACRX) News Today → Millionaire investor and Republican donor makes surprising election prediction (From InvestorPlace) (Ad) Free Acrx Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative January 11, 2024 | markets.businessinsider.comTalphera’s Strategic Rebrand and Niyad’s Market Potential Bolster Buy RatingJanuary 9, 2024 | msn.comAcelRx announces rebranding with name change to TalpheraJanuary 9, 2024 | finance.yahoo.comAcelRx Announces Rebranding With Name Change to Talphera, Inc.December 22, 2023 | benzinga.comAcelRx Pharmaceuticals Stock (NASDAQ:ACRX) Dividends: History, Yield and DatesDecember 12, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United StatesNovember 22, 2023 | msn.comAcelRx Pharmaceuticals files for $150M mixed shelfNovember 9, 2023 | finanznachrichten.deAcelRx Pharmaceuticals, Inc.: AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 7, 2023 | msn.comAcelRx Pharmaceuticals Q3 2023 Earnings PreviewNovember 7, 2023 | finance.yahoo.comAcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad™ Clinical StudyOctober 26, 2023 | finance.yahoo.comAcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023October 3, 2023 | finance.yahoo.comAcelRx Receives IDE Approval for Niyad and Advances to a Single Registration StudySeptember 12, 2023 | msn.comAcelRx CEO buys 10,000 sharesSeptember 12, 2023 | finance.yahoo.comInsider Buying: CEO Vincent Angotti Acquires 10,000 Shares of AcelRx Pharmaceuticals IncAugust 22, 2023 | finance.yahoo.comWhat Makes AcelRx Pharmaceuticals (ACRX) a New Buy StockAugust 18, 2023 | markets.businessinsider.comPositive Report for Acelrx (ACRX) from H.C. WainwrightAugust 13, 2023 | finance.yahoo.comAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call TranscriptAugust 12, 2023 | finanznachrichten.deAcelRx Pharmaceuticals, Inc.: AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 11, 2023 | finance.yahoo.comQ2 2023 AcelRx Pharmaceuticals Inc Earnings CallAugust 11, 2023 | finance.yahoo.comAcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 11, 2023 | finance.yahoo.comAcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Tops Revenue EstimatesJuly 28, 2023 | finance.yahoo.comAcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023July 21, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq RulesJuly 18, 2023 | seekingalpha.comAcelRx Pharmaceuticals launches ~$10M private placement of sharesJuly 18, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesJune 17, 2023 | finance.yahoo.comACRX - AcelRx Pharmaceuticals, Inc.June 16, 2023 | fool.comAcelRx Pharmaceuticals (NASDAQ: ACRX)May 13, 2023 | finanznachrichten.deAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 11, 2023 | msn.comRecap: AcelRx Pharmaceuticals Q1 EarningsMay 10, 2023 | finance.yahoo.comAcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1May 10, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 4, 2023 | finance.yahoo.comEarnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q1 Earnings Expected to DeclineMay 3, 2023 | msn.comAcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseApril 27, 2023 | finance.yahoo.comAcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023April 5, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora PharmaceuticalsApril 4, 2023 | finance.yahoo.comAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q4 2022 Earnings Call TranscriptMarch 31, 2023 | finanznachrichten.deAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate UpdateMarch 31, 2023 | markets.businessinsider.comAcelrx (ACRX) Receives a Hold from H.C. WainwrightMarch 30, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate UpdateMarch 29, 2023 | msn.comEarnings Outlook For AcelRx PharmaceuticalsMarch 21, 2023 | finance.yahoo.comAcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023March 14, 2023 | marketwatch.comAcelRx Pharmaceuticals Shares Rise Premarket on Dsuvia Sale >ACRXMarch 14, 2023 | msn.comAcelRx adds 16% on plans to divest pain therapyMarch 14, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora PharmaceuticalsFebruary 24, 2023 | thestreet.comHere's Why AcelRx Pharmaceuticals (ACRX) Stock Gained TodayJanuary 18, 2023 | forbes.comAcelrx PharmaceuticalsDecember 29, 2022 | finance.yahoo.comAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call TranscriptDecember 27, 2022 | finance.yahoo.comAcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common StockDecember 27, 2022 | marketbeat.comThree Healthcare Penny Stocks to Watch In The New YearThese three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.December 26, 2022 | marketbeat.comThree Healthcare Penny Stocks to Watch In The New Year (ACRX)These three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.December 26, 2022 | benzinga.comLooking Into AcelRx Pharmaceuticals's Return On Capital Employed Get AcelRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here ACRX Media Mentions By Week ACRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACRX News Sentiment▼0.000.58▲Average Medical News Sentiment ACRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACRX Articles This Week▼00▲ACRX Articles Average Week Get AcelRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Pieris Pharmaceuticals News Today Edesa Biotech News Today NanoViricides News Today Tonix Pharmaceuticals News Today Vaxxinity News Today Aytu BioPharma News Today Kiora Pharmaceuticals News Today ABVC BioPharma News Today FSD Pharma News Today Cocrystal Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACRX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithMillionaire investor and Republican donor makes surprising election predictionInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AcelRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
